Institutional shares held 13.4 Million
13.1K calls
21.3K puts
Total value of holdings $1.2M
$1K calls
$1K puts
Market Cap $3.08M
34,212,900 Shares Out.
Institutional ownership 39.09%
# of Institutions 54


Latest Institutional Activity in EYEN

Top Purchases

Q3 2024
Armistice Capital, LLC Shares Held: 8.53M ($768K)
Q3 2024
Diametric Capital, LP Shares Held: 158K ($14.2K)
Q3 2024
Geode Capital Management, LLC Shares Held: 558K ($50.2K)
Q3 2024
Financial Management Network Inc Shares Held: 81.3K ($7.31K)
Q3 2024
Prelude Capital Management, LLC Shares Held: 57.5K ($5.18K)

Top Sells

Q3 2024
Jane Street Group, LLC Shares Held: 38.2K ($3.44K)
Q3 2024
Northern Trust Corp Shares Held: 61.5K ($5.53K)
Q3 2024
Bank Of America Corp Shares Held: 421 ($37.9)
Q3 2024
Susquehanna International Group, LLP Shares Held: 29.9K ($2.69K)
Q3 2024
Sky View Investment Advisors, LLC Shares Held: 100K ($9K)

About EYEN

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.


Insider Transactions at EYEN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
2.12M Shares
From 8 Insiders
Grant, award, or other acquisition 369K shares
Open market or private purchase 1.75M shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on EYEN

Follow EYENOVIA, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYEN shares.

Notify only if

Insider Trading

Get notified when an Eyenovia, Inc. insider buys or sells EYEN shares.

Notify only if

News

Receive news related to EYENOVIA, INC.

Track Activities on EYEN